珍しいp.Thr244Proヘテロジゴス型変異によって引き起こされるIMPDH1遺伝子に関連した棒型ジストロフィーの疾患進行
Mirella Barboni1,2, Eszter Jávorszky3, Mathieu Quinodoz4
1Department of Ophthalmology, Semmelweis University, Budapest, Hungary. mirella.barboni@semmelweis.hu.
Documenta ophthalmologica. Advances in ophthalmology
|February 15, 2026
まとめ
希少なIMPDH1遺伝子の変異が,軽度の棒-型ジストロフィーを引き起こした. 患者は中央視力を維持したが,急速に進行する形態とは異なり,安定した外周視力の喪失があった.
科学分野:
- オフタルモロジック (眼科)
- 遺伝学 遺伝学とは
- 分子生物学は分子生物学である.
背景:
- ロッド・コーン・ディストロフィー (RCD) は,漸進的な視力喪失を特徴とする遺伝性網膜疾患のグループです.
- イノシンモノホスファート脱水素酵素1 (IMPDH1) 遺伝子は,RCDのいくつかの形態に関与しており,しばしば表情性が変動する.
- 遺伝子型-フェノタイプ相関は,疾患メカニズムを理解し,IMPDH1に関連するRCDの進行を予測するために重要である.
研究 の 目的:
- 希少な de novo IMPDH1ミスセンスの変異によって引き起こされるRCDの患者の詳細な臨床的特徴を提供するために.
- 特定のIMPDH1変種p.Thr244Pro.の遺伝子型-フェノタイプ相関を調査する.
- この変異体が光受容体機能に及ぼす構造的,機能的な影響を理解するために.
主な方法:
- RCDを患っている33歳の女性患者は,4年間のマルチモダルの評価を受けました.
- 方法には,構造的 (SD-OCT) と機能的 (BCVA,マイクロペリメトリー,カラービジョン,ERG,視野) 評価が含まれていました.
- 分子解析により,IMPDH1遺伝子の de novoミスセンスの変種が確認されました:c.730A>C,p.Thr244Pro.
主要な成果:
- 特定されたIMPDH1変種 (p.Thr244Pro) は,核酸結合とフィードバック調節に関与する重要なインターフェースに位置しています.
- SD-OCTでは,中央の円形の領域が保存されているが,外周神経網膜の損失を示した.
- 機能検査では正常な視力敏度と中心機能が示され,多焦点ERGの軽度な低下と,外周機能不全と一致する全場ERGが影響を受けた.
結論:
- IMPDH1のp.Thr244Pro変異は,保存された中央網膜の構造と機能と関連しています.
- 患者は40代で安定した外周機能不全を示し,病気の進行が遅くなったことを示した.
- これは,他のIMPDH1関連の網膜縮症に見られる典型的な急速な進行と対照的です.
関連する概念動画
Gene Flow
38.1K
Gene flow is the transfer of genes among populations, resulting from either the dispersal of gametes or from the migration of individuals.
38.1K
Histone Variants at the Centromere
5.1K
Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3...
5.1K
Satellite Stem Cells and Muscular Dystrophy
2.4K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.4K
Gene Evolution - Fast or Slow?
8.2K
The genomes of eukaryotes are punctuated by long stretches of sequence which do not code for proteins or RNAs. Although some of these regions do contain crucial regulatory sequences, the vast majority of this DNA serves no known function. Typically, these regions of the genome are the ones in which the fastest change, in evolutionary terms, is observed, because there is typically little to no selection pressure acting on these regions to preserve their sequences.
In contrast, regions which code...
In contrast, regions which code...
8.2K
Tumor Progression
7.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.5K
Gene Therapy
27.7K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.7K


